Comments
Loading...

Keros Therapeutics

KROSNASDAQ
Logo brought to you by Benzinga Data
$17.03
0.110.65%
At close: -
$17.01
-0.02-0.12%
After Hours: Dec 20, 7:24 PM EDT

Keros Therapeutics (NASDAQ:KROS) Stock, Earnings Estimates, EPS, And Revenue

Keros Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 26
EPS Estimate
$-1.220
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)
$651K

Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Keros Therapeutics (KROS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-06$-1.41$-1.27-11.0 %
Jun 20242024-08-07$-1.25$-1.23-1.63 %
Mar 20242024-05-08$-1.21$-1.349.70 %
Dec 20232024-02-28$-1.34$-1.372.19 %

Keros Therapeutics (KROS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20232023-08-07$0$220.00K-100.0 %
Mar 20232023-05-04$0$220.00K-100.0 %
Dec 20222023-03-03$0$860.00K-100.0 %

FAQ

Q

When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?

A

Keros Therapeutics (KROS) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Keros Therapeutics (NASDAQ:KROS)?

A

The Actual EPS was $-1.41, which missed the estimate of $-1.27.

Q

What were Keros Therapeutics’s (NASDAQ:KROS) revenues?

A

The Actual Revenue was $388K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch